Cytomegalovirus infection in liver-transplanted children
- PMID: 35317177
- PMCID: PMC8891677
- DOI: 10.4254/wjh.v14.i2.338
Cytomegalovirus infection in liver-transplanted children
Abstract
Cytomegalovirus (CMV) infection is a common complication of liver trans-plantation in children. The CMV serostatus of recipients and donors is the primary risk factor, and prophylaxis or pre-emptive strategies are recommended for high-risk patients. Graft rejection, coinfection and Epstein-Bar virus reactivation, which can lead to post-transplant lymphoproliferative disease, are indirect effects of CMV infection. Assessment of CMV infection viral load should be routinely performed upon clinical suspicion. However, tissue-invasive CMV disease is not associated with CMV viraemia and requires confirmation by tissue pathology. Oral valganciclovir and intravenous ganciclovir are equivalent treatments, and the duration of treatment depends on factors including CMV viral load, tissue pathology, and clinical response. Risk stratification by donor and recipient status prior to transplantation and post-transplantation antiviral prophylaxis or pre-emptive therapy are recommended. Adult guidelines have been established but additional study of the effectiveness of the preventive guidelines in children is needed. This review summarizes the burden, risk factors, clinical manifestations, laboratory evaluation, treatment, and prevention of CMV infection in children after liver transplantation.
Keywords: Children; Cytomegalovirus; Infection; Liver transplantation; Pediatric.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflicting interests.
Figures


Similar articles
-
Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?Transplant Proc. 2005 Sep;37(7):3182-6. doi: 10.1016/j.transproceed.2005.07.032. Transplant Proc. 2005. PMID: 16213344
-
Cytomegalovirus infection after liver transplantation: current concepts and challenges.World J Gastroenterol. 2008 Aug 21;14(31):4849-60. doi: 10.3748/wjg.14.4849. World J Gastroenterol. 2008. PMID: 18756591 Free PMC article. Review.
-
Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.Transpl Infect Dis. 2019 Feb;21(1):e13015. doi: 10.1111/tid.13015. Epub 2018 Nov 19. Transpl Infect Dis. 2019. PMID: 30358023
-
Prophylaxis versus pre-emptive treatment for prevention of cytomegalovirus infection in CMV-seropositive orthotopic liver-transplant recipients.J Med Virol. 2015 May;87(5):836-44. doi: 10.1002/jmv.23964. Epub 2015 Feb 5. J Med Virol. 2015. PMID: 25655981
-
Management of cytomegalovirus infection and disease in liver transplant recipients.World J Hepatol. 2014 Jun 27;6(6):370-83. doi: 10.4254/wjh.v6.i6.370. World J Hepatol. 2014. PMID: 25018848 Free PMC article. Review.
Cited by
-
A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients.Front Pediatr. 2023 Sep 4;11:1252495. doi: 10.3389/fped.2023.1252495. eCollection 2023. Front Pediatr. 2023. PMID: 37732007 Free PMC article. Review.
-
Management of cytomegalovirus infection after liver transplantation.World J Transplant. 2024 Sep 18;14(3):93209. doi: 10.5500/wjt.v14.i3.93209. World J Transplant. 2024. PMID: 39295968 Free PMC article. Review.
References
-
- Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin Infect Dis. 2017;64:87–91. - PubMed
-
- Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin S, eds. Multidisciplinary approach to understanding cytomegalovirus disease. Amsterdam: Excerpta Medica International Congress Series. Amsterdam: Elsevier Science, 1993: 233-237.
-
- Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20:202–213. - PubMed
-
- Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–276. - PubMed
Publication types
LinkOut - more resources
Full Text Sources